{"id":772366,"date":"2023-07-25T16:41:21","date_gmt":"2023-07-25T20:41:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/"},"modified":"2023-07-25T16:41:21","modified_gmt":"2023-07-25T20:41:21","slug":"miromatrix-to-report-second-quarter-2023-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/","title":{"rendered":"Miromatrix to Report Second Quarter 2023 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">EDEN PRAIRIE, Minn., July  25, 2023  (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients\u2019 lives, today announced that the Company will report financial results for the second quarter 2023 after market close on Monday, August 14, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time \/ 4:30 pm Eastern Time.<\/p>\n<p>Individuals interested in listening to the conference call may do so by dialing 866-652-5200 for domestic callers or 412-317-6060 for international callers. Please reference Conference ID: 10181369. To listen to a live webcast, please visit the investor relations section of Miromatrix&#8217;s website at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lvy1ivJLo86BMOPgLsyCVGlXWEUIXZS2rVm5vhyBPfyXOTTuiHjN_G4SUFta4-BHZ-Vsg9wwI_mmA0iDM2etEcJuCDHqR3dzvTibofDbs__p2pIH244X2ODqhHJLXVvJ\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/miromatrix.gcs-web.com\/<\/a><\/p>\n<p>\n        <strong>About Miromatrix<\/strong><br \/>\n        <br \/>Miromatrix Medical Inc.\u00a0is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients&#8217; lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company&#8217;s initial development focus is on human livers and kidneys. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxcycvota_ka1yTY5_r6EfoJ6f8IQXKftNT9fktzQdYCfKHeS__zne8ZxXts4F9rmuZGZZlB0JwQOYrKs70h0aRdRv2uvHgSWRUMqvs2tjZ12L_VIQPxh7OglYS26-N7hnNE97es65z82AxI1E57mavg4DmFwtPm5x5gw7xkbmsJfDxIm3nrt3cc1YO4qlwyNFspGE9XuoPDvxTxCvvTnn4p9_0O6IPjvTLVA91DieXOGL0nD88696VLxWrw4rYknDzkMgcf-2508F8KOScAIfGv3nnlzyaQYSBF1eE48RAeOIS4VofXGabpBDvLuT0wtEixZc40QzZd5K-9GbQNq5PZFkYTcJOmRfYFnkkd-_0kFhpSlVaUjoXiBvXTRgNyGbm7VwLSijtu8CCNOOd5iWzTgWy6OpP-91lT4qWDD3cI49jWuxVdeoZjYiVZ204_sVjUR5ChLAWqqpU_P3un5L77Vx6KRUA3RNtgzDqXMahM455of_iQAoM65kgyu7OOehmrvMpCAki4aQpAMAn0tlWTUVGPl7M2ZxMKPpnQGOBi87b-HBO4qctiekg9Hg_vm5LFK6cuY9KPrKZGUksBLiRYZc_blfyRoTmX1CvkMLdlrJjBAHaJfqjU58u55xdDX9ZhnEHHCWiVbkFs2zNoXTHX1NJ1901hd1etHjJ0odo=\" rel=\"nofollow noopener\" target=\"_blank\">miromatrix.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Greg Chodaczek<br \/>347-620-7010 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xi5AtqBsX65SdCEz2hUdV_vf2Vww_H5siWLsc32vxyZt7EDXoIuk9lLe6wmM8k54KtJjHgowJIv9H23dlvjEaY7ZAnVc6n7BeqJzS89Vuy4=\" rel=\"nofollow noopener\" target=\"_blank\">ir@miromatrix.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eJ34GUnRFeS_VKSF1W39ySgsVA71ZIqupPb4kQ6LJe2ziWdgwE6iv-h3jhqgf3n1hG5SXPiaEBIWlXIBHkqMmWJBpDmIZYq6t7WMkpEbTa4=\" rel=\"nofollow noopener\" target=\"_blank\">press@miromatrix.com<\/a>\n      <\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTBjNjMxZGQtZTY2OS00ZTg1LWI3YjgtY2E1ZjkxZDYzNzhmLTEyMjIwNzM=\/tiny\/Miromatrix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients\u2019 lives, today announced that the Company will report financial results for the second quarter 2023 after market close on Monday, August 14, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time \/ 4:30 pm Eastern Time. Individuals interested in listening to the conference call may do so by dialing 866-652-5200 for domestic callers or 412-317-6060 for international callers. Please reference Conference ID: 10181369. To listen to a live webcast, please visit the investor relations section of Miromatrix&#8217;s website at: https:\/\/miromatrix.gcs-web.com\/ About &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Miromatrix to Report Second Quarter 2023 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772366","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients\u2019 lives, today announced that the Company will report financial results for the second quarter 2023 after market close on Monday, August 14, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time \/ 4:30 pm Eastern Time. Individuals interested in listening to the conference call may do so by dialing 866-652-5200 for domestic callers or 412-317-6060 for international callers. Please reference Conference ID: 10181369. To listen to a live webcast, please visit the investor relations section of Miromatrix&#8217;s website at: https:\/\/miromatrix.gcs-web.com\/ About &hellip; Continue reading &quot;Miromatrix to Report Second Quarter 2023 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T20:41:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Miromatrix to Report Second Quarter 2023 Financial Results\",\"datePublished\":\"2023-07-25T20:41:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/\"},\"wordCount\":206,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/\",\"name\":\"Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\",\"datePublished\":\"2023-07-25T20:41:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-to-report-second-quarter-2023-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Miromatrix to Report Second Quarter 2023 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk","og_description":"EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) &#8212; Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients\u2019 lives, today announced that the Company will report financial results for the second quarter 2023 after market close on Monday, August 14, 2023. Company management will host a corresponding conference call beginning at 3:30 pm Central Time \/ 4:30 pm Eastern Time. Individuals interested in listening to the conference call may do so by dialing 866-652-5200 for domestic callers or 412-317-6060 for international callers. Please reference Conference ID: 10181369. To listen to a live webcast, please visit the investor relations section of Miromatrix&#8217;s website at: https:\/\/miromatrix.gcs-web.com\/ About &hellip; Continue reading \"Miromatrix to Report Second Quarter 2023 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-25T20:41:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Miromatrix to Report Second Quarter 2023 Financial Results","datePublished":"2023-07-25T20:41:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/"},"wordCount":206,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/","name":"Miromatrix to Report Second Quarter 2023 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=","datePublished":"2023-07-25T20:41:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4MDU1OSM1NzA4ODYzIzIyMTA1MjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-to-report-second-quarter-2023-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Miromatrix to Report Second Quarter 2023 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772366"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772366\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}